Rapid Micro Biosystems, Inc. RPID
Regular-session close
After hours · Nov 19, 4:24 PM ET
- YTD
- -74.64%
- 1 year
- -83.14%
5D -0.0051 (-0.69%)
- Market cap
- 37.38M
- Revenue (ttm)
- 26.17M
- Profit margin
- -184.93%
- EPS (ttm)
- -1.06
- Shares out
- 37.72M
- Forward P/E
- -1.02
- YTD return
- -74.64%
- 1-year return
- -83.14%
- Volume
- 690.48K
- Avg volume
- 550.63K
- Open
- 0.736
- Previous close
- 0.7376
- Day's range
- 0.7353 – 0.7366
- 52-week range
- 0.62 – 4.68
- Beta
- 1.08
- Price target
- 8.00 (+988.0%)
Key statistics
- 50-day average
- 1.04
- 200-day average
- 0.88566
- Enterprise value
- -15.08M
- Price / sales
- 1.50
- Price / book
- 0.47
- Revenue growth
- 23.70%
- Total cash
- 60.83M
- Total debt
- 6.45M
- Return on equity
- -45.62%
- Short % of float
- 0.15%
Fundamental scorecard
7 of 25 checks passed on RPID’s reported financials
7of 25 checks passed
- Value 1 of 5
- Growth 2 of 5
- Profitability 1 of 5
- Financial health 3 of 5
- Dividend 0 of 5
Statements to Jun 30, 2026.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 1, 2024 | Sep 1, 2024 | -0.26 | -0.26 | 0.00 | 0.00% |
| Aug 2, 2024 | Jun 1, 2024 | -0.28 | -0.29 | -0.01 | -3.57% |
| Aug 2, 2024 | Jun 1, 2024 | -0.28 | — | — | — |
| May 3, 2024 | Mar 1, 2024 | -0.29 | -0.31 | -0.02 | -6.90% |
| May 3, 2024 | Mar 1, 2024 | -0.29 | — | — | — |
| Mar 1, 2024 | Dec 1, 2023 | -0.31 | -0.26 | +0.05 | +16.13% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 7, 2023 | Morgan Stanley | reit | — | Equal-Weight |
| Aug 16, 2022 | JP Morgan | down | Overweight | Neutral |
| May 11, 2022 | Morgan Stanley | main | — | Equal-Weight |
| Mar 7, 2022 | Morgan Stanley | main | — | Equal-Weight |
| Feb 15, 2022 | Morgan Stanley | main | — | Equal-Weight |
| Nov 15, 2021 | Morgan Stanley | main | — | Equal-Weight |
About Rapid Micro Biosystems, Inc.
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- rapidmicrobio.com
News
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Rapid Micro Biosystems, Inc. (NASDAQ: RPID)
Are GLND, RPID, AYTU Obtaining Fair Deals for their Shareholders?
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Aytu BioPharma, Inc. (Nasdaq – AYTU), Rapid Micro Biosystems, Inc. (Nasdaq – RPID), Advantage Energy Ltd. (OTC – AAVVF), Canaccord Genuity Group Inc. (OTC – CCORF)
RPID Stock Alert: Halper Sadeh LLC is Investigating Whether Rapid Micro Biosystems, Inc. is Obtaining a Fair Price for its Shareholders
RPID Shareholder Alert: ADEMI LLP Investigates Whether Buyout Fairly Values Rapid Micro Biosystems, Inc.
Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Beats Revenue Estimates
Merck KGaA, Darmstadt, Germany Signs Definitive Agreement to Acquire Rapid Micro Biosystems, Advancing Automation in Pharmaceutical Quality Control Rapid Micro Biosystems Q3 EPS $(0.23) Misses $(0.20) Estimate, Sales $9.528M Miss $10.000M Estimate
Merck KGaA Agrees To Acquire Rapid Micro Biosystems At Price Of $0.75/Shr In All-Cash Transaction
Rapid Micro Biosystems Reports Third Quarter 2026 Financial Results
Your note
Sign in to keep a note on RPID — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| HIRSCH DAVID | Director | Stock Award(Grant) | May 22, 2024 | 14,300 |
| KOLLENDER RICHARD S | Director | Purchase | Aug 5, 2024 | 96,718 |
| LOWENSTEIN INESE | Director | Stock Award(Grant) | May 22, 2024 | 24,300 |
| MALLOY KIRK | Director | Purchase | Aug 7, 2024 | 64,300 |
| PEI MELINDA LITHERLAND | Director | Purchase | Dec 4, 2024 | 54,300 |
| RICCIARDI NATALE S | Director | Stock Award(Grant) | May 22, 2024 | 14,300 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 22.36% | 8,434,560 | 7.69M | Sep 29, 2024 |
| Kennedy Lewis Management LP | 13.09% | 4,939,931 | 4.50M | Sep 29, 2024 |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 2.75% | 1,038,296 | 946.82K | Sep 29, 2024 |
| Vanguard Group Inc | 1.93% | 726,560 | 662.55K | Sep 29, 2024 |
| Advent International LP | 1.53% | 577,777 | 526.87K | Sep 29, 2024 |
| Blackrock Inc. | 1.52% | 572,879 | 522.41K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.58% | 594,568 | 542.19K | Sep 29, 2024 |
| BlackRock Health Sciences Term Trust | 1.51% | 571,184 | 520.86K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.31% | 116,325 | 106.08K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.23% | 85,828 | 78.27K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.06% | 21,258 | 19.39K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.06% | 21,522 | 19.63K | Oct 30, 2024 |
